Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 479

1.

Assessment of the efficacy of buspirone in patients affected by generalized anxiety disorder, shifting to buspirone from prior treatment with lorazepam: a placebo-controlled, double-blind study.

Delle Chiaie R, Pancheri P, Casacchia M, Stratta P, Kotzalidis GD, Zibellini M.

J Clin Psychopharmacol. 1995 Feb;15(1):12-9.

PMID:
7714222
[PubMed - indexed for MEDLINE]
2.

Buspirone and lorazepam in the treatment of generalized anxiety disorder in outpatients.

Laakmann G, Schüle C, Lorkowski G, Baghai T, Kuhn K, Ehrentraut S.

Psychopharmacology (Berl). 1998 Apr;136(4):357-66.

PMID:
9600581
[PubMed - indexed for MEDLINE]
3.

A double-blind, placebo-controlled study comparing the efficacy and safety of ipsapirone versus lorazepam in patients with generalized anxiety disorder: a prospective multicenter trial.

Cutler NR, Sramek JJ, Keppel Hesselink JM, Krol A, Roeschen J, Rickels K, Schweizer E.

J Clin Psychopharmacol. 1993 Dec;13(6):429-37.

PMID:
7907097
[PubMed - indexed for MEDLINE]
4.

Treatment of generalized anxiety disorder: preliminary clinical experience with buspirone.

Petracca A, Nisita C, McNair D, Melis G, Guerani G, Cassano GB.

J Clin Psychiatry. 1990 Sep;51 Suppl:31-9. Review.

PMID:
2211564
[PubMed - indexed for MEDLINE]
5.

Abecarnil for the treatment of generalized anxiety disorder: a placebo-controlled comparison of two dosage ranges of abecarnil and buspirone.

Pollack MH, Worthington JJ, Manfro GG, Otto MW, Zucker BG.

J Clin Psychiatry. 1997;58 Suppl 11:19-23.

PMID:
9363044
[PubMed - indexed for MEDLINE]
6.

Controlled comparison of the effects and abrupt discontinuation of buspirone and lorazepam.

Bourin M, Malinge M.

Prog Neuropsychopharmacol Biol Psychiatry. 1995 Jul;19(4):567-75.

PMID:
8588056
[PubMed - indexed for MEDLINE]
7.

Nonorganic insomnia in generalized anxiety disorder. 2. Comparative studies on sleep, awakening, daytime vigilance and anxiety under lorazepam plus diphenhydramine (Somnium) versus lorazepam alone, utilizing clinical, polysomnographic and EEG mapping methods.

Saletu B, Saletu-Zyhlarz G, Anderer P, Brandstätter N, Frey R, Gruber G, Klösch G, Mandl M, Grünberger J, Linzmayer L.

Neuropsychobiology. 1997;36(3):130-52.

PMID:
9313245
[PubMed - indexed for MEDLINE]
8.

Efficacy, safety, and tolerability of venlafaxine extended release and buspirone in outpatients with generalized anxiety disorder.

Davidson JR, DuPont RL, Hedges D, Haskins JT.

J Clin Psychiatry. 1999 Aug;60(8):528-35.

PMID:
10485635
[PubMed - indexed for MEDLINE]
9.

Imipramine and buspirone in treatment of patients with generalized anxiety disorder who are discontinuing long-term benzodiazepine therapy.

Rickels K, DeMartinis N, García-España F, Greenblatt DJ, Mandos LA, Rynn M.

Am J Psychiatry. 2000 Dec;157(12):1973-9.

PMID:
11097963
[PubMed - indexed for MEDLINE]
10.

[Efficacy and withdrawal of clobazam, lorazepam and buspirone in the treatment of anxiety disorders].

Lemoine P, Rouillon F, Pouget D.

Encephale. 1996 Nov-Dec;22(6):461-7. French.

PMID:
10901839
[PubMed - indexed for MEDLINE]
11.

Safety of ipsapirone treatment compared with lorazepam: discontinuation effects.

Busto UE, Naranjo CA, Bremner KE, Peachey JE, Bologa M.

J Psychiatry Neurosci. 1998 Jan;23(1):35-44.

PMID:
9505058
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

[Comparison of 6 different methods for lorazepam withdrawal. A controlled study, hydroxyzine versus placebo].

Lemoine P, Touchon J, Billardon M.

Encephale. 1997 Jul-Aug;23(4):290-9. French.

PMID:
9417395
[PubMed - indexed for MEDLINE]
13.

Efficacy of buspirone in generalized anxiety disorder with coexisting mild depressive symptoms.

Sramek JJ, Tansman M, Suri A, Hornig-Rohan M, Amsterdam JD, Stahl SM, Weisler RH, Cutler NR.

J Clin Psychiatry. 1996 Jul;57(7):287-91.

PMID:
8666569
[PubMed - indexed for MEDLINE]
14.

A double-blind, controlled trial in primary care patients with generalized anxiety: a comparison between buspirone and oxazepam.

Strand M, Hetta J, Rosen A, Sörensen S, Malmström R, Fabian C, Marits K, Vetterskog K, Liljestrand AG, Hegen C.

J Clin Psychiatry. 1990 Sep;51 Suppl:40-5.

PMID:
2211567
[PubMed - indexed for MEDLINE]
15.

A comparative study of suriclone, lorazepam and placebo in anxiety disorder.

de Jonghe F, Swinkels J, Tuynman-Qua H, Jonkers F.

Pharmacopsychiatry. 1989 Nov;22(6):266-71.

PMID:
2575766
[PubMed - indexed for MEDLINE]
16.

Controlled comparison of buspirone and oxazepam in generalized anxiety.

Ansseau M, Papart P, Gérard MA, von Frenckell R, Franck G.

Neuropsychobiology. 1990-1991;24(2):74-8.

PMID:
2134114
[PubMed - indexed for MEDLINE]
17.

Comparison of withdrawal of buspirone and diazepam: a placebo controlled study.

Fontaine R, Beaudry P, Beauclair L, Chouinard G.

Prog Neuropsychopharmacol Biol Psychiatry. 1987;11(2-3):189-97.

PMID:
2888159
[PubMed - indexed for MEDLINE]
18.

Alprazolam versus buspirone in the treatment of outpatients with generalized anxiety disorder.

Enkelmann R.

Psychopharmacology (Berl). 1991;105(3):428-32.

PMID:
1798836
[PubMed - indexed for MEDLINE]
19.

Placebo-controlled comparison of the clinical effects of rapid discontinuation of ipsapirone and lorazepam after 8 weeks of treatment for generalized anxiety disorder.

Mandos LA, Rickels K, Cutler N, Roeschen J, Keppel Hesselink JM, Schweizer E.

Int Clin Psychopharmacol. 1995 Nov;10(4):251-6.

PMID:
8748047
[PubMed - indexed for MEDLINE]
20.

[A controlled double-blind study of tetrabamate versus lorazepam and placebo in generalized anxiety].

Lôo H, Malka R, Hantouche E, Lancrenon S, Guelfi JD.

Encephale. 1991 Jul-Aug;17(4):295-300. French.

PMID:
1959498
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk